Detailed Answer
Erectile dysfunction (ED) is defined as the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance.¹ It may significantly impact psychosocial health and quality of life for both patients and their partners.² The EAU Guidelines recommend a personalized approach to ED treatment that starts with lifestyle changes and uses oral medications (PDE5 inhibitors) as first-line therapy, with other options chosen according to effectiveness, invasiveness and patient preference.³ First-line treatments include oral phosphodiesterase type 5 inhibitors (PDE5Is) such as sildenafil, tadalafil, vardenafil, and avanafil, which are effective in about 70% of men with ED.⁴ However, when these medications fail or are contraindicated, second-line treatments like vacuum erection devices, intracavernosal injections, or intraurethral alprostadil may be considered.⁵ These options have varying success rates but can be effective alternatives for many patients. For men who don’t respond to or cannot use other treatments, penile implants (penile prostheses) are a highly effective surgical option with one of the highest satisfaction rates of any ED treatment.⁶ The EAU Guidelines recognize two main types of penile implants: malleable (semi-rigid) and inflatable (2-piece and 3-piece) prostheses.⁷ Patients may prefer the 3-piece inflatable prosthesis because it gives a more natural erection, although no randomized trials have compared satisfaction between implant types.⁸ According to the guidelines, patient satisfaction rates with penile implants are exceptionally high, exceeding 90% in most studies.⁹ Partner satisfaction rates are similarly high, at 91-95%.¹⁰ These high satisfaction rates are attributed to the reliable, on-demand erections that implants provide, allowing for spontaneous sexual activity without the need for pre-planning or medication.¹¹ The EAU Guidelines note that complications of penile implant surgery have decreased significantly with technological improvements and surgical refinements. With the most commonly used three-piece devices, mechanical failure rates are below 5% after five years.¹² Infection and mechanical failure are the two main complications; with careful surgical technique and antibiotic prophylaxis, infection occurs in about 2-3% of first-time implantations in low-risk patients at high-volume centers, and antibiotic-coated or hydrophilic-coated implants can lower this to about 1-2%.¹³ Patients should be counseled about realistic expectations, including that the implant will not increase penile length and is not designed to restore previous penile length.¹⁴ When considering treatment options for ED, the guidelines emphasize the importance of shared decision-making between the patient, their partner, and healthcare provider.¹⁵ While penile implants represent the most effective solution for severe ED, the choice of treatment should be individualized based on the patient’s specific situation, preferences, and goals.¹⁶
From the Guidelines
"Implant a penile prosthesis if other treatments fail or depending upon patient preference." (p. 57) "The surgical implantation of a penile prosthesis may be considered in patients who i) are not suitable for different pharmacotherapies or prefer a definitive therapy; and, ii) do not respond to other treatment modalities." (p. 55)